Delivery Order SPE2DR25D3401-SPE2DR26FL0RN
Award Date 12/16/25
Potential Completion Date 12/17/25
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,229.56 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Zepbound 10 mg/0.5 mL pen (semaglutide), a medication used for weight management. This firm fixed-price, non-set-aside delivery order will be completed by August 29, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded a delivery order valued at $10,077.59 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist medication primarily used for weight management. Issued on November 18, 2025, with completion expected by November 19, 2025, this firm fixed-price delivery order contains no set-aside designation and represents a competitive award under an existing contract vehicle. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $9,140.61 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen (semaglutide), a GLP-1 receptor agonist medication used for weight management. This firm fixed-price delivery order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen (semaglutide injection), a diabetes and weight management medication. The contract, valued at $29,770.98, is a firm fixed-price delivery order with a completion date of October 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,205.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen (semaglutide injection), a GLP-1 receptor agonist commonly prescribed for weight management. This firm fixed-price delivery order, awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for ZEPBOUND 10 mg/0.5 ml pen (semaglutide injection), a GLP-1 receptor agonist indicated for weight management. The contract was competitively awarded without set-aside restrictions and carries a firm fixed price structure, with an ultimate completion date of July 21, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency has awarded a delivery order valued at $2,669.03 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens. This competitive award, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a firm fixed price transaction for pharmaceutical delivery to support federal medical supply needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $2,460 delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens in 0.5 mL doses. The order is non-competitive and utilizes firm fixed pricing under a delivery order contract type, with an ultimate completion date of November 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,875.17 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist used for weight management. This firm fixed price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by August 4, 2025. The contract was awarded on August 1, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location, the...
- The Defense Logistics Agency awarded a delivery order valued at $3,050.32 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order was placed under a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award reflects the agency's need for this...